Zhiguo M. Niu

Henan Key Laboratory Of Immunology And Targeted Drugs
Xinxiang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Correction: RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.

Correction: RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.

Journal: Cell death & disease

Published: February 05, 2026

Repurposing Diclofenac as an Anticancer Agent: Suppression of Breast Cancer and Progression through EPAS1-EFNA1 Regulation.

Repurposing Diclofenac as an Anticancer Agent: Suppression of Breast Cancer and Progression through EPAS1-EFNA1 Regulation.

Journal: Current medicinal chemistry

Published: August 14, 2025

Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury.

Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury.

Journal: JHEP reports : innovation in hepatology

Published: November 18, 2022

RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.

RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.

Journal: Cell death & disease

Published: September 01, 2022

UHRF1 modulates breast cancer cell growth via estrogen signaling.

UHRF1 modulates breast cancer cell growth via estrogen signaling.

Journal: Medical oncology (Northwood, London, England)

Published: January 29, 2022

TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression.

TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression.

Journal: Cell communication and signaling : CCS

Published: October 07, 2021

The E3 Ubiquitin Ligase HOIP inhibits Cancer Cell Apoptosis via modulating PTEN stability.

The E3 Ubiquitin Ligase HOIP inhibits Cancer Cell Apoptosis via modulating PTEN stability.

Journal: Journal of Cancer

Published: April 24, 2021

Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187.

Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187.

Journal: Cell death & disease

Published: April 13, 2021

ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.

ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.

Journal: Cancer science

Published: January 01, 2021

ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells.

ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells.

Journal: Frontiers in oncology

Published: December 07, 2020

The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression.

The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression.

Journal: Journal of Cancer

Published: July 09, 2020

IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival.

IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival.

Journal: EMBO molecular medicine

Published: March 09, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026